FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy
Kidney Research and Clinical Practice · 20.08.2026
DOI: 10.23876/j.krcp.25.389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 20.08.2026. Verfasst von Liqin Mu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of General Medicine, First Hospital of Hebei Medical University, Shijiazhuang, China. wangjing2024q@163.com.
Zitieren
APA
Mu, L., Zhao, Y., Li, Y., Gao, W., & Wang, J. (2026). FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.25.389
Vancouver
Mu L, Zhao Y, Li Y, Gao W, Wang J. FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.25.389
BibTeX
@article{Mu2026,
author = {Mu, Liqin and Zhao, Yu and Li, Yang and Gao, Wei and Wang, Jing},
title = {FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy},
journal = {Kidney Research and Clinical Practice},
year = {2026},
doi = {10.23876/j.krcp.25.389}
}
EUVIMED